Research Site — Detroit, Michigan

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

688

Registered studies

235

Active

108

Recruiting now

362

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Locally Advanced Unresectable Gastroesophageal Junction (GEJ)… · Ovarian Cancer · Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT04589845 — Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You… (Active Not Recruiting)
NCT07357597 — An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd)… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.